Tenax Therapeutics, Inc. · NASDAQ:TENX
Point72 Asset Management, L.P. reported a 6.80% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Point72 Asset Management, L.P. reported a 6.80% stake in Tenax Therapeutics, Inc., 423,415 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 423,415
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 6.80% | 423,415 |
| Point72 Capital Advisors, Inc. | 6.80% | 423,415 |
| Steven A. Cohen | 6.80% | 423,415 |
Source
Related
- Tenax Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Oct 29, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026